This Undervalued Company's Expansion Plans Could Spell Big Gains
This discount grocer hired a former Wal-Mart exec as its CEO and is already seeing results. An aggressive plan to open 100 new discount stores should lead to big gains for shareholders in the years ahead.

The Stock to Own in this Out-of-Favor Sector
This high-flying airline should flourish in a rising economy, but its balance sheet should also provide a strong cushion if we hit bumpy skies again.

The Most Important Thing to Remember as an Investor in Oil
It's hard to know exactly how much oil will cost in a few months. The best bet oil investors have is to buy oil so low, that it can't get any cheaper. And guess what, it's easier than you think.

Why 2010 is THE Year for This Investment
An improving economy and historically low valuations have created an ideal situation for this sector.

An Undervalued Industry Leader with +66% Upside Potential
This insurance company has increased its dividend for 26 straight years, grown revenue for more than a decade and trades at a steep discount to its historical valuations. Shares could jump +66% as they approach their historic valuation.

Looking Beyond Banks to Uncover Truly Excellent Value
Bank balance sheets might make banks seem like great values, though very few are. These two securities, however, sidestep the minefield of financial institutions and not only offer investors a truly good deal but also offer rich dividend income.

Don't Miss the Best Pharma Value on the Market
One of the market's most well-known drug giants is trading at single digit valuations -- a value that won't last long. Plus, the company has paid dividends for more than 120 years and yields 5.5%.

Why I'm Buying This Stock
Tuesday's earnings announcement is likely to provide a pop for these troubled shares after JP Morgan's revenue misses expectations and sends banks lower.

The Company Poised to Rebound with the Improving Economy
As the long economic downturn subsides, consumers will begin to re-enter a market they abandoned when the housing bubble burst. That's one very good reason to invest in this industry leader.

40 Million People Need This Life-Saving Drug
This pharmaceutical company has the highest operating margins in the industry, and it has the exclusive rights to its money-making drugs for another decade.

Is This Tiny Stock the Next Exxon -- Or the Next Budweiser?
This investment could make anyone who listens filthy rich. The company owns a unique living compound with huge potential in the production of cellulosic ethanol -- a market with +15,900% government-mandated growth ahead. Who knows how high this stock is headed? I don't. But it's so cheap now that making 100x your money is possible once the technology goes mainstream. Click here for more details.